Dainippon Sumitomo Pharma Co Ltd 3
3 · Roivant Sciences Ltd. · Filed Oct 1, 2021
Insider Transaction Report
Form 3
Sumitomo Chemical Co., Ltd.
10% Owner
Holdings
- 86,367,360(indirect: See Footnote)
Common Shares
Footnotes (1)
- [F1]Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon") directly owns 86,367,360 Common Shares. Sumitomo Dainippon is a 51.78% owned subsidiary of Sumitomo Chemical Co., Ltd. ("Sumitomo"). Sumitomo may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended) the reported securities that Sumitomo Dainippon owns. Sumitomo disclaims beneficial ownership of such reported securities except to the extent of its pecuniary interest therein.